Sarah N Cross1, Rachel A Nelson1, Julie A Potter1, Errol R Norwitz2, Vikki M Abrahams1. 1. Department of Obstetrics, Gynecology & Reproductive Sciences, Yale School of Medicine, New Haven, CT, USA. 2. Department of Obstetrics & Gynecology, Tufts University School of Medicine, Boston, MA, USA.
Abstract
PROBLEM: Chorioamnionitis and infection-associated inflammation are major causes of preterm birth. Magnesium sulfate (MgSO4 ) is widely used in obstetrics as a tocolytic; however, its mechanism of action is unclear. This study sought to investigate how MgSO4 modulates infection-associated inflammation in fetal membranes (FMs), and whether the response was time dependent. METHOD OF STUDY: Human FM explants were treated with or without bacterial lipopolysaccharide (LPS); with or without MgSO4 added either: 1 hour before LPS; at the same time as LPS; 1 hour post-LPS; or 2 hours post-LPS. Explants were also treated with or without viral dsRNA and LPS, alone or in combination; and MgSO4 added 1 hour post-LPS After 24 hours, supernatants were measured for cytokines/chemokines; and tissue lysates measured for caspase-1 activity. RESULTS: Lipopolysaccharide-induced FM inflammation by upregulating the secretion of a number of inflammatory cytokines/chemokines. Magnesium sulfate administered 1-hour post-LPS inhibited FM secretion of IL-1β, IL-6, G-CSF, RANTES, and TNFα. Magnesium sulfate administered 2 hours post-LPS augmented FM secretion of these factors as well as IL-8, IFNγ, VEGF, GROα and IP-10. Magnesium sulfate delivered 1- hour post-LPS inhibited LPS-induced caspase-1 activity, and inhibited the augmented IL-1β response triggered by combination viral dsRNA and LPS. CONCLUSION: Magnesium sulfate differentially modulates LPS-induced FM inflammation in a time-dependent manner, in part through its modulation of caspase-1 activity. Thus, the timing of MgSO4 administration may be critical in optimizing its anti-inflammatory effects in the clinical setting. MgSO4 might also be useful at preventing FM inflammation triggered by a polymicrobial viral-bacterial infection.
PROBLEM: Chorioamnionitis and infection-associated inflammation are major causes of preterm birth. Magnesium sulfate (MgSO4 ) is widely used in obstetrics as a tocolytic; however, its mechanism of action is unclear. This study sought to investigate how MgSO4 modulates infection-associated inflammation in fetal membranes (FMs), and whether the response was time dependent. METHOD OF STUDY: Human FM explants were treated with or without bacterial lipopolysaccharide (LPS); with or without MgSO4 added either: 1 hour before LPS; at the same time as LPS; 1 hour post-LPS; or 2 hours post-LPS. Explants were also treated with or without viral dsRNA and LPS, alone or in combination; and MgSO4 added 1 hour post-LPS After 24 hours, supernatants were measured for cytokines/chemokines; and tissue lysates measured for caspase-1 activity. RESULTS:Lipopolysaccharide-induced FM inflammation by upregulating the secretion of a number of inflammatory cytokines/chemokines. Magnesium sulfate administered 1-hour post-LPS inhibited FM secretion of IL-1β, IL-6, G-CSF, RANTES, and TNFα. Magnesium sulfate administered 2 hours post-LPS augmented FM secretion of these factors as well as IL-8, IFNγ, VEGF, GROα and IP-10. Magnesium sulfate delivered 1- hour post-LPS inhibited LPS-induced caspase-1 activity, and inhibited the augmented IL-1β response triggered by combination viral dsRNA and LPS. CONCLUSION:Magnesium sulfate differentially modulates LPS-induced FM inflammation in a time-dependent manner, in part through its modulation of caspase-1 activity. Thus, the timing of MgSO4 administration may be critical in optimizing its anti-inflammatory effects in the clinical setting. MgSO4 might also be useful at preventing FM inflammation triggered by a polymicrobial viral-bacterial infection.
Authors: O Dowling; P K Chatterjee; M Gupta; H B Tam Tam; X Xue; D Lewis; B Rochelson; C N Metz Journal: Placenta Date: 2012-02-16 Impact factor: 3.481
Authors: Matthew W Kemp; Masatoshi Saito; John P Newnham; Ilias Nitsos; Kunihiro Okamura; Suhas G Kallapur Journal: Reprod Sci Date: 2010-07 Impact factor: 3.060
Authors: Ingrid Cardenas; Robert E Means; Paulomi Aldo; Kaori Koga; Sabine M Lang; Carmen J Booth; Carmen Booth; Alejandro Manzur; Enrique Oyarzun; Roberto Romero; Gil Mor Journal: J Immunol Date: 2010-06-16 Impact factor: 5.422
Authors: Haruka Suzuki-Kakisaka; Jun Sugimoto; Manas Tetarbe; Andrea M Romani; Christina M Ramirez Kitchen; Helene B Bernstein Journal: Am J Reprod Immunol Date: 2013-04-17 Impact factor: 3.886
Authors: Mai Hoang; Julie A Potter; Stefan M Gysler; Christina S Han; Seth Guller; Errol R Norwitz; Vikki M Abrahams Journal: Biol Reprod Date: 2014-02-27 Impact factor: 4.285
Authors: Monica Cappelletti; Pietro Presicce; Matthew J Lawson; Vandana Chaturvedi; Traci E Stankiewicz; Simone Vanoni; Isaac Tw Harley; Jaclyn W McAlees; Daniel A Giles; Maria E Moreno-Fernandez; Cesar M Rueda; Paranth Senthamaraikannan; Xiaofei Sun; Rebekah Karns; Kasper Hoebe; Edith M Janssen; Christopher L Karp; David A Hildeman; Simon P Hogan; Suhas G Kallapur; Claire A Chougnet; Sing Sing Way; Senad Divanovic Journal: JCI Insight Date: 2017-03-09
Authors: Julie A Potter; Mancy Tong; Paulomi Aldo; Ja Young Kwon; Mary Pitruzzello; Gil Mor; Vikki M Abrahams Journal: J Reprod Immunol Date: 2020-04-08 Impact factor: 4.054